Search for other papers by Navid Tabriz in
Google Scholar
PubMed
Search for other papers by Kilian Gloy in
Google Scholar
PubMed
Search for other papers by Astrid Schantzen in
Google Scholar
PubMed
Search for other papers by Dennis Fried in
Google Scholar
PubMed
Search for other papers by Dirk Weyhe in
Google Scholar
PubMed
Search for other papers by Verena Uslar in
Google Scholar
PubMed
.5; 17.9–41) 28.3 (5.1; 18.4–44.4) Current treatment L-thyroxine ( n ; %) 9 (9.2) 0 9 (13.0) Antithyroid drugs ( n ; %) 34 (34.7) 28 (96.6) 6 (8.7) Iodine ( n ; %) 3 (3.1) 0 3 (4.3) None ( n
Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Search for other papers by Vera Schempp in
Google Scholar
PubMed
Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Search for other papers by Michaela Marx in
Google Scholar
PubMed
Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
, antithyroid drug; BR, block and replace; C, carbimazole; D, dose titration; f, female; m, male; LT4, levothyroxine; M, methimazole. The clinical characteristics of children with GD and DS in comparison with GD children without DS are shown in Tables
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Search for other papers by Marijn M Bult in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Endocrinology and Metabolism, Amsterdam, The Netherlands
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
, however, not investigate the use of other drugs, such as antithyroid drugs, beta-blockers, or glucocorticoids which could have influenced fT4 results as well and should ideally be looked at in future (prospective) studies ( 11 ). We found that an fT4
Search for other papers by Selma Flora Nordqvist in
Google Scholar
PubMed
Search for other papers by Victor Brun Boesen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Per Karkov Cramon in
Google Scholar
PubMed
Department of Internal Medicine, Herlev Gentofte Hospital, Copenhagen, Denmark
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark
Search for other papers by Mogens Groenvold in
Google Scholar
PubMed
National Research Centre for the Working Environment, Copenhagen, Denmark
QualityMetric Incorporated, LLC, Johnston, Rhode Island, USA
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
HF Hallengren B Holmberg M Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves’ hyperthyroidism: a long-term follow-up with the thyroid-related patient-reported outcome questionnaire
Department of Endocrinology, The People’s Hospital of Daxing District, Beijing, China
Search for other papers by Ya-Fen Hu in
Google Scholar
PubMed
Search for other papers by Lin Hua in
Google Scholar
PubMed
Search for other papers by Xiu Tuo in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Yi-Lin Yang in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong-Yu Yan in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
history was within 1 year. Among them, 28 subjects were hyperthyroid, 4 were euthyroid, and 3 were hypothyroid. All subjects with hyperthyroidism received only antithyroid drugs (Thyrozol, Merck Company) and underwent CT scan of the orbits, which excluded
Search for other papers by Jiayang Lin in
Google Scholar
PubMed
Search for other papers by Peizhen Zhang in
Google Scholar
PubMed
Search for other papers by Yan Huang in
Google Scholar
PubMed
Search for other papers by Xueyun Wei in
Google Scholar
PubMed
Search for other papers by Dan Guo in
Google Scholar
PubMed
Search for other papers by Jianfang Liu in
Google Scholar
PubMed
Search for other papers by Deying Liu in
Google Scholar
PubMed
Search for other papers by Yajuan Deng in
Google Scholar
PubMed
Search for other papers by Bingyan Xu in
Google Scholar
PubMed
Search for other papers by Chensihan Huang in
Google Scholar
PubMed
Search for other papers by Xiaoyu Yang in
Google Scholar
PubMed
Search for other papers by Yan Lu in
Google Scholar
PubMed
Search for other papers by Lijing Jia in
Google Scholar
PubMed
Search for other papers by Huijie Zhang in
Google Scholar
PubMed
questionnaire, including social-demographic status, life style and medical history. Subjects who had cancer, current treatment with antithyroid drugs or systemic corticosteroids, pregnancy, lactation, subacute thyroiditis, abnormal kidney function, and
Search for other papers by Boni Xiang in
Google Scholar
PubMed
Search for other papers by Ran Tao in
Google Scholar
PubMed
Search for other papers by Xinhua Liu in
Google Scholar
PubMed
Search for other papers by Xiaoming Zhu in
Google Scholar
PubMed
Search for other papers by Min He in
Google Scholar
PubMed
Search for other papers by Zengyi Ma in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Yiming Li in
Google Scholar
PubMed
Search for other papers by Zhenwei Yao in
Google Scholar
PubMed
Search for other papers by Yongfei Wang in
Google Scholar
PubMed
Search for other papers by Hongying Ye in
Google Scholar
PubMed
hyperthyroidism after surgery and even led to the medication of antithyroid drugs. The aim of our study was to evaluate the thyroid functions of patients with CS, compare the hormone levels in patients with different etiologies, and investigate the clinical
Search for other papers by Xuan Luo in
Google Scholar
PubMed
Search for other papers by Tingting Zheng in
Google Scholar
PubMed
Institute of Oncology, The Affiliated Hospital of Jiangsu University, Zhenjiang, China
Search for other papers by Chaoming Mao in
Google Scholar
PubMed
Search for other papers by Xin Dong in
Google Scholar
PubMed
Search for other papers by Xiao Mou in
Google Scholar
PubMed
Search for other papers by Chengcheng Xu in
Google Scholar
PubMed
Search for other papers by Qingyan Lu in
Google Scholar
PubMed
Search for other papers by Baocui Liu in
Google Scholar
PubMed
Search for other papers by Shengjun Wang in
Google Scholar
PubMed
Search for other papers by Yichuan Xiao in
Google Scholar
PubMed
thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves’ disease . European Journal of Endocrinology 2007 156 623 – 630 . ( https://doi.org/10.1530/EJE-07-0019 ) 17535861 22 Kimura H
Search for other papers by Ru-Xuan Zhao in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Sha Luo in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
group, 24 patients were considered to be hyperthyroid and another 24 to be euthyroid at the time of assessment, and only patients in the former category were treated with antithyroid drugs. Thyroid function in the control group matched that in the active
Search for other papers by M L M Barreto-Chaves in
Google Scholar
PubMed
Search for other papers by N Senger in
Google Scholar
PubMed
Search for other papers by M R Fevereiro in
Google Scholar
PubMed
Search for other papers by A C Parletta in
Google Scholar
PubMed
Search for other papers by A P C Takano in
Google Scholar
PubMed
treatment with antithyroid drugs and can be reversible after total thyroidectomy ( 51 ). In addition, the combination of antithyroid therapy and beta blockers, to control heart rate, prevents hemodynamic overload and cardiac remodeling leading to complete